|
Ypsomed Holding AG (0qlq.l) Valoración de DCF |
Completamente Editable: Adáptelo A Sus Necesidades En Excel O Sheets
Diseño Profesional: Plantillas Confiables Y Estándares De La Industria
Predeterminadas Para Un Uso Rápido Y Eficiente
Compatible con MAC / PC, completamente desbloqueado
No Se Necesita Experiencia; Fáciles De Seguir
Ypsomed Holding AG (0QLQ.L) Bundle
Diseñada para la precisión, nuestra calculadora DCF YPSOMED Holding AG (0QLQL) DCF le permite evaluar la valoración de YPsomed Holting Ag utilizando datos financieros del mundo real, ofreciendo una flexibilidad completa para modificar todos los parámetros esenciales para mejorar las proyecciones.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2020 |
AY2 2021 |
AY3 2022 |
AY4 2023 |
AY5 2024 |
FY1 2025 |
FY2 2026 |
FY3 2027 |
FY4 2028 |
FY5 2029 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 403.7 | 464.8 | 497.5 | 548.5 | 748.9 | 878.0 | 1,029.4 | 1,206.8 | 1,414.9 | 1,658.9 |
| Revenue Growth, % | 0 | 15.16 | 7.02 | 10.25 | 36.54 | 17.24 | 17.24 | 17.24 | 17.24 | 17.24 |
| EBITDA | 63.9 | 92.5 | 137.5 | 161.8 | 190.9 | 207.8 | 243.6 | 285.6 | 334.9 | 392.6 |
| EBITDA, % | 15.82 | 19.89 | 27.64 | 29.5 | 25.49 | 23.67 | 23.67 | 23.67 | 23.67 | 23.67 |
| Depreciation | 56.0 | 68.1 | 78.6 | 74.9 | 79.9 | 120.5 | 141.3 | 165.7 | 194.2 | 227.7 |
| Depreciation, % | 13.88 | 14.65 | 15.79 | 13.65 | 10.68 | 13.73 | 13.73 | 13.73 | 13.73 | 13.73 |
| EBIT | 7.8 | 24.4 | 58.9 | 86.9 | 111.0 | 87.3 | 102.3 | 120.0 | 140.6 | 164.9 |
| EBIT, % | 1.94 | 5.25 | 11.85 | 15.85 | 14.82 | 9.94 | 9.94 | 9.94 | 9.94 | 9.94 |
| Total Cash | 22.4 | 17.0 | 25.2 | 74.0 | 36.5 | 57.3 | 67.2 | 78.8 | 92.4 | 108.3 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 72.7 | 87.0 | 93.3 | 141.0 | 203.5 | 190.3 | 223.1 | 261.6 | 306.7 | 359.5 |
| Account Receivables, % | 18 | 18.71 | 18.76 | 25.71 | 27.17 | 21.67 | 21.67 | 21.67 | 21.67 | 21.67 |
| Inventories | 64.9 | 70.4 | 59.0 | 75.3 | 85.8 | 119.9 | 140.5 | 164.8 | 193.2 | 226.5 |
| Inventories, % | 16.07 | 15.14 | 11.87 | 13.73 | 11.45 | 13.65 | 13.65 | 13.65 | 13.65 | 13.65 |
| Accounts Payable | 34.6 | 17.4 | 19.6 | 30.9 | 37.4 | 47.2 | 55.3 | 64.8 | 76.0 | 89.1 |
| Accounts Payable, % | 8.56 | 3.74 | 3.94 | 5.63 | 4.99 | 5.37 | 5.37 | 5.37 | 5.37 | 5.37 |
| Capital Expenditure | -126.6 | -127.4 | -169.2 | -195.3 | -277.1 | -290.4 | -340.5 | -399.2 | -468.1 | -548.8 |
| Capital Expenditure, % | -31.36 | -27.41 | -34.01 | -35.61 | -37.01 | -33.08 | -33.08 | -33.08 | -33.08 | -33.08 |
| Tax Rate, % | 16.12 | 16.12 | 16.12 | 16.12 | 16.12 | 16.12 | 16.12 | 16.12 | 16.12 | 16.12 |
| EBITAT | 7.4 | 22.1 | 53.4 | 83.2 | 93.1 | 79.5 | 93.2 | 109.3 | 128.2 | 150.3 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -166.1 | -74.3 | -30.0 | -90.0 | -170.6 | -101.5 | -151.3 | -177.4 | -208.0 | -243.8 |
| WACC, % | 9.09 | 9.08 | 9.08 | 9.09 | 9.07 | 9.08 | 9.08 | 9.08 | 9.08 | 9.08 |
| PV UFCF | ||||||||||
| SUM PV UFCF | -661.5 | |||||||||
| Long Term Growth Rate, % | 3.50 | |||||||||
| Free cash flow (T + 1) | -252 | |||||||||
| Terminal Value | -4,520 | |||||||||
| Present Terminal Value | -2,927 | |||||||||
| Enterprise Value | -3,588 | |||||||||
| Net Debt | 231 | |||||||||
| Equity Value | -3,819 | |||||||||
| Diluted Shares Outstanding, MM | 14 | |||||||||
| Equity Value Per Share | -279.80 |
Benefits of Choosing Ypsomed Holding AG (0QLQL)
- Genuine Ypsomed Data: Preloaded financial metrics – covering everything from revenue to EBIT – derived from real and forecasted figures.
- Complete Customization: Modify all essential parameters (yellow cells) such as WACC, growth %, and tax rates to fit your analysis needs.
- Instant Valuation Refresh: Automatic recalculations to help assess how adjustments influence the fair value of Ypsomed Holding AG (0QLQL).
- Flexible Excel Template: Designed for quick modifications, scenario analysis, and comprehensive projections.
- Efficient and Precise: Eliminate the need to start models from scratch while ensuring both accuracy and adaptability.
Key Features
- 🔍 Real-Life Ypsomed Financials: Pre-filled historical and projected data for Ypsomed Holding AG (0QLQL).
- ✏️ Fully Customizable Inputs: Modify all essential parameters (yellow cells) such as WACC, growth %, and tax rates.
- 📊 Professional DCF Valuation: Integrated formulas calculate the intrinsic value of Ypsomed using the Discounted Cash Flow method.
- ⚡ Instant Results: Visualize Ypsomed's valuation immediately after adjustments.
- Scenario Analysis: Analyze and compare outcomes based on different financial assumptions side-by-side.
How It Operates
- Download the Template: Gain immediate access to the Excel-based Ypsomed Holding AG DCF Calculator.
- Input Your Assumptions: Modify the yellow-highlighted cells for growth rates, WACC, profit margins, and additional parameters.
- Instant Calculations: The model will automatically refresh to display Ypsomed Holding AG's intrinsic value.
- Test Scenarios: Experiment with various assumptions to assess potential changes in valuation.
- Analyze and Decide: Utilize the results to inform your investment strategy or financial evaluation.
Why Choose This Calculator for Ypsomed Holding AG (0QLQL)?
- Designed for Industry Experts: A sophisticated tool tailored for analysts, CFOs, and consultants.
- Accurate Financial Data: Ypsomed’s historical and projected financial information preloaded for precision.
- Dynamic Scenario Analysis: Effortlessly test various forecasts and assumptions.
- Comprehensive Outputs: Instantly calculates intrinsic value, NPV, and essential metrics.
- User-Friendly Interface: Step-by-step guidance ensures a smooth navigation experience.
Who Should Utilize Ypsomed Holding AG (0QLQL)?
- Finance Students: Master valuation methods and practice them with actual market data.
- Academics: Integrate established financial models into your teaching or research projects.
- Investors: Evaluate your hypotheses and assess valuation scenarios for Ypsomed Holding AG (0QLQL).
- Analysts: Optimize your analysis process with a ready-to-use, adaptable DCF model.
- Small Business Owners: Discover how major publicly traded companies like Ypsomed Holding AG (0QLQL) are evaluated.
Contents of the Template
- Operating and Balance Sheet Data: Pre-filled historical data and forecasts for Ypsomed Holding AG (0QLQL), including metrics such as revenue, EBITDA, EBIT, and capital expenditures.
- WACC Calculation: A specific sheet dedicated to the Weighted Average Cost of Capital (WACC), featuring key parameters like Beta, risk-free rate, and share price.
- DCF Valuation (Unlevered and Levered): Customizable Discounted Cash Flow models that illustrate intrinsic value with comprehensive calculations.
- Financial Statements: Pre-loaded annual and quarterly financial statements to facilitate analysis.
- Key Ratios: Includes essential profitability, leverage, and efficiency ratios pertaining to Ypsomed Holding AG (0QLQL).
- Dashboard and Charts: A visual overview of valuation outputs and underlying assumptions for easy result analysis.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.